Howard Dorfman to Address ACI Forum on Advertising and Promotions for the Pharmaceutical Industry

Practices: Life Sciences

The Carton Hotel New York, NY

Howard Dorfman, counsel in the Life Sciences practice group of Ropes & Gray, will address the American Conference Institute's upcoming Corporate Counsel Forum on Advertising and Promotions for the Pharmaceutical Industry in New York. Forum topics will include:  
  • Examining restrictions on pharmaceutical manufacturer activities
  • Case studies of inequitable conduct
  • Consequences of receipt of a warning or untitled letter for pre-approval promotion
  • Managing regulatory limitations on pre-approval company activities during the final stages of FDA review
  • Advising the healthcare community of imminent product availability while remaining compliant
  • Reviewing FDA regulatory activity and establishing appropriate in-house compliance and education processes
  • Maintaining an acceptable separation of science and promotion in press releases announcing clinical trial results
  • Presenting clinical trial data in a scientific and objective manner
  • Guidance on scientific exchange
  • Beyond FDA – the increasing oversight by the Department of Justice, the OIG, and the SEC
Cookie Settings